X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (49) 49
humans (44) 44
male (38) 38
cardiac & cardiovascular systems (36) 36
female (36) 36
middle aged (28) 28
cardiovascular (26) 26
aged (23) 23
adult (22) 22
risk factors (21) 21
atrial fibrillation (20) 20
stroke (20) 20
abridged index medicus (17) 17
retrospective studies (15) 15
cardiac arrhythmia (14) 14
risk (13) 13
ablation (12) 12
electrocardiography (11) 11
treatment outcome (11) 11
analysis (10) 10
article (10) 10
adolescent (9) 9
cardiology (9) 9
care and treatment (9) 9
follow-up studies (9) 9
heart (9) 9
prevention (9) 9
stroke - etiology (9) 9
sudden cardiac death (9) 9
warfarin (9) 9
aged, 80 and over (8) 8
anticoagulants (8) 8
atrial fibrillation - complications (8) 8
diagnosis (8) 8
patients (8) 8
population (8) 8
proportional hazards models (8) 8
stroke - prevention & control (8) 8
therapy (8) 8
young adult (8) 8
atrial fibrillation - drug therapy (7) 7
comorbidity (7) 7
internal medicine (7) 7
mortality (7) 7
safety (7) 7
time factors (7) 7
administration, oral (6) 6
bleeding (6) 6
death, sudden, cardiac - epidemiology (6) 6
fibrillation (6) 6
heart beat (6) 6
neurosciences (6) 6
rivaroxaban (6) 6
age (5) 5
anticoagulants - administration & dosage (5) 5
arrhythmia (5) 5
atrial fibrillation - physiopathology (5) 5
atrial fibrillation - surgery (5) 5
brain (5) 5
cardiac patients (5) 5
catheter ablation - adverse effects (5) 5
cohort studies (5) 5
complications (5) 5
confidence intervals (5) 5
health aspects (5) 5
management (5) 5
medical colleges (5) 5
prevalence (5) 5
research (5) 5
risk assessment (5) 5
stroke prevention (5) 5
studies (5) 5
tachycardia (5) 5
united states - epidemiology (5) 5
anticoagulants - adverse effects (4) 4
anticoagulation (4) 4
arrhythmias (4) 4
arrhythmias, cardiac - genetics (4) 4
aspirin (4) 4
association (4) 4
atrial fibrillation - diagnosis (4) 4
catheter ablation (4) 4
catheter ablation - methods (4) 4
clinical neurology (4) 4
clinical trials (4) 4
common variants (4) 4
dabigatran (4) 4
defibrillators (4) 4
drug therapy (4) 4
genome-wide association study (4) 4
hemorrhage - chemically induced (4) 4
hospitals (4) 4
hypertension (4) 4
kidney diseases (4) 4
medical research (4) 4
medicine & public health (4) 4
medicine, experimental (4) 4
medicine, general & internal (4) 4
multicenter (4) 4
original research (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 23, pp. 2779 - 2790
Abstract Background Dose reduction of non–vitamin K antagonist oral anticoagulants (NOACs) is indicated in patients with atrial fibrillation (AF) with renal... 
Cardiovascular | Internal Medicine | kidney disease | dose | bleeding | embolism | stroke | CARDIAC & CARDIOVASCULAR SYSTEMS | SAFETY | RIVAROXABAN | RISK | APIXABAN | MDRD | CARE | COCKCROFT-GAULT | DABIGATRAN | WARFARIN | United States - epidemiology | Dabigatran - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Antithrombins - administration & dosage | Rivaroxaban - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Dose-Response Relationship, Drug | Young Adult | Pyridones - administration & dosage | Time Factors | Aged, 80 and over | Adult | Female | Renal Insufficiency - complications | Stroke - epidemiology | Retrospective Studies | Vitamin K | Stroke - prevention & control | Hemorrhage - epidemiology | Administration, Oral | Atrial Fibrillation - drug therapy | Atrial Fibrillation - complications | Treatment Outcome | Pyrazoles - administration & dosage | Stroke - etiology | Adolescent | Aged | Hemorrhage - chemically induced | Stroke (Disease) | Medical policy | Care and treatment | Atrial fibrillation | Health care industry | Anticoagulants (Medicine) | Kidney diseases | Medical research | Chronic kidney failure | Medicine, Experimental | Heart | Cardiac arrhythmia | Renal function | Embolisms | Indication | Impairment | Risk | Data bases | Bleeding | Training | Prevention | Confidence intervals | Fibrillation | Databases | Ischemia | Safety | Drug dosages | Anticoagulants | Dosing | Stroke | Statistical analysis | Regression | Labels | Hazards | Marking | Patients | Embolism | Disease prevention | Oral cavity | Renal failure | Health hazards | Clinical medicine | Kidney transplantation
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2016, Volume 117, Issue 7, pp. 1117 - 1126
Journal Article
Heart Rhythm, ISSN 1547-5271, 2012, Volume 9, Issue 10, pp. 1627 - 1634
Journal Article
Heart Rhythm, ISSN 1547-5271, 2016, Volume 13, Issue 7, pp. 1418 - 1424
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2009, Volume 104, Issue 1, pp. 128 - 132
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 25, pp. 3020 - 3021
  Nonetheless, these observational data provide a glimpse at real-world clinical outcomes associated with NOAC use for patients with HCM and AF, a group not... 
Cardiovascular | Internal Medicine | TASK-FORCE | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | Care and treatment | Anticoagulants (Medicine) | Atrial fibrillation | Risk factors | Confidence intervals | Anticoagulants | Cardiac arrhythmia | Stroke | Embolisms | Cardiomyopathy
Journal Article